Lupin launches generic solution of pneumonia in US

Pharma/BioPharma |  News | 0 Comment | 13 Nov, 2018

Pharma major Lupin has announced the launch of Atovaquone Oral Suspension USP, 750 mg/5 mL having received an approval from the United States Food and Drug Administration (FDA) earlier. Lu...Read more

Biocon's Bengaluru plant completes USFDA inspection without any observations

Pharma/BioPharma |  News | 0 Comment | 12 Nov, 2018

Biotechnology major Biocon said that the US health regulator has completed inspection of its new manufacturing facility in Bengaluru without any observations. "The United States Food and D...Read more

Strides enters into partnership with SUDA Pharma for migraine drug

Pharma/BioPharma |  News | 0 Comment | 09 Nov, 2018

Strides Pharma Science Limited (Strides)  has announced  that  its  step‐down  wholly  owned  subsidiary,  Strides  Pharma  Global  ...Read more

AstraZeneca to sell rights of Alvesco, Omnaris, Zetonna

Pharma/BioPharma |  News | 0 Comment | 07 Nov, 2018

AstraZeneca has entered into an agreement with Covis Pharma B.V. (Covis Pharma) to sell its rights to the medicines Alvesco (ciclesonide), used for the treatment of persistent asthma, and O...Read more

Lupin receives FDA approval for Doxercalciferol Injection

Pharma/BioPharma |  News | 0 Comment | 05 Nov, 2018

Pharma major Lupin has received approval for its Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multi-dose Vials from the United States Food and Drug Administration (FDA) to market a gene...Read more

Biocon ranks 7th on global Pharma & Biotech employers list 2018

Pharma/BioPharma |  News | 0 Comment | 30 Oct, 2018

Biocon Ltd, Asia’s premier biopharmaceuticals company, has moved up in the Top 10 Global Biotech Employers ranking for 2018 and continues to be the only Company from Asia to feature o...Read more

Biocon, Mylan receive positive CHMP opinion for Ogivri

Pharma/BioPharma |  News | 0 Comment | 19 Oct, 2018

Biocon Ltd. and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval...Read more

Piramal Pharma becomes Industry Partner of the Year

Pharma/BioPharma |  News | 0 Comment | 19 Oct, 2018

Piramal Pharma Solutions (PPS) has been recognized as the Industry Partner of the Year at the prestigious Global Generics & Biosimilars Awards 2018, held recently in Madrid, Spain. This...Read more

OPPI releases Shaping India’s OTC Policy 2018

Pharma/BioPharma |  News | 0 Comment | 12 Oct, 2018

On behalf of the pharmaceutical industry in India, the Organisation of Pharmaceutical Producers of India (OPPI), along with a few members from the domestic pharmaceutical industry and consu...Read more

OPPI advocates for policies that promote scientific temperament

Pharma/BioPharma |  News | 0 Comment | 11 Oct, 2018

The Organisation of Pharmaceutical Producers of India (OPPI) celebrated their 52nd Annual Day recently. Themed #HealthMeetsHope, the Chief Guest of the Annual Day celebrations, Shri. Sidhar...Read more

Armas, Shilpa ink distribution pact for oncology products

Pharma/BioPharma |  News | 0 Comment | 09 Oct, 2018

Armas Pharmaceuticals Inc., a NJ based pharmaceutical marketing & distribution corporation, and Shilpa Medicare Limited, a Karnataka based pharmaceutical company, have announced a distr...Read more

Zydus receives final approval for Exemestane Tablets

Pharma/BioPharma |  News | 0 Comment | 05 Oct, 2018

Zydus Cadila has received the final approval from the USFDA to market Exemestane Tablets, (US RLD – AROMASIN Tablets), 25 mg. It will be manufactured at the group’s formulations...Read more

Lupin, Lilly partner for innovative diabetes treatment in India

Pharma/BioPharma |  News | 0 Comment | 03 Oct, 2018

Pharma Major Lupin Limited and Eli Lilly and Company (India) Pvt. Ltd., have announced the expansion of their business partnership aimed at widening access to innovative diabetes medicines ...Read more

Rotavirus vaccine options expand with WHO prequalification

Pharma/BioPharma |  News | 0 Comment | 28 Sep, 2018

PATH welcomes the World Health Organization's (WHO's) prequalification of the thermostable rotavirus vaccine, ROTASIIL, manufactured by Serum Institute of India. The vaccine, which prevents...Read more

AstraZeneca receives European marketing authorisation for Imfinzi

Pharma/BioPharma |  News | 0 Comment | 25 Sep, 2018

AstraZeneca and MedImmune, its global biologics research and development arm, have announced that the European Commission has granted marketing authorisation for Imfinzi (durvalumab) as mon...Read more

Glenmark gets USFDA approval for menopause symptom relief drug

Pharma/BioPharma |  News | 0 Comment | 17 Sep, 2018

Glenmark Pharmaceuticals has received final approval from the US health regulator for a generic version of Nordisk Inc's VAGIFEM, used for providing relief from menopause symptom. Glenmark...Read more

Alembic Pharma receives approval for diabetes drug

Pharma/BioPharma |  News | 0 Comment | 16 Sep, 2018

Alembic Pharmaceuticals has said that it has received tentative approval from the US health regulator to market Alogliptin and Metformin Hydrochloride tablets, an anti-diabetes medication, ...Read more

Kusum Group launches Rs 90 Cr Manufacturing Plant in Indore

Pharma/BioPharma |  News | 0 Comment | 12 Sep, 2018

Pharmaceutical major Kusum Group of Companies has announced the launch of its latest 90 crore Indore plant at the special economic zone in Pithampur. Built on an area of over 4.88 acres, th...Read more